imiquimod has been researched along with Breast Cancer in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Maharjan, S; Mitragotri, S; Pan, DC; Singh, B; Zhang, YS; Zhao, Z | 1 |
| Boll, D; Bulten, J; de Hullu, JA; Esajas, MD; Meeuwis, KA; van Beurden, M; van der Linden, M; van Dorst, EB; van Hees, CL; van Poelgeest, MI | 1 |
| Benedetto, C; Bertero, L; Borella, F; Gallio, N; Micheletti, L; Pérez-López, FR; Preti, M; Vieira-Baptista, P | 1 |
| Guo, X; Li, X; Liu, L; Wang, Y; Wei, X; Zhao, J; Zhou, S | 1 |
| Adams, S; Bedognetti, D; Chiriboga, L; Darvishian, F; Demaria, S; Egeblad, M; Heguy, A; Hendrickx, W; Loomis, C; Marincola, FM; Ray, K; Rozenblit, M | 1 |
| Bahoric, B; Basik, M; Batist, G; Guay, MP; Henriques, L; Kavan, P; Palumbo, M | 1 |
| Allison, KH; Childs, JS; Coveler, AL; Dang, Y; Disis, ML; Higgins, DM; Lu, H; Reichow, JL; Salazar, LG; Waisman, J | 1 |
| Carson, J; Jenkinson, H; O'Kane, D | 1 |
| Adams, S; Axelrod, D; Bhardwaj, N; Chiriboga, L; Demaria, S; Formenti, SC; Goldberg, JD; Hochman, T; Kozhaya, L; Liebes, L; Martiniuk, F; Meng, TC; Novik, Y; Shuman, N; Speyer, J; Tiersten, A; Unutmaz, D | 1 |
| Kohrt, H | 1 |
| Bieber, T; Haller, O; Tueting, T; Uerlich, M; Wenzel, J | 1 |
| Hengge, UR; Roth, S; Tannapfel, A | 1 |
| Martínez, MI; Mihm, MC; Sanchez-Carpintero, I | 1 |
| Ammoury, A; Bazex, J; El Sayed, F; Lamant, L; Messer, L; Mirer, E | 1 |
1 review(s) available for imiquimod and Breast Cancer
| Article | Year |
|---|---|
Langerhans cell histiocytosis associated with breast carcinoma successfully treated with topical imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Histiocytosis, Langerhans-Cell; Humans; Imiquimod; Middle Aged; Treatment Outcome | 2009 |
3 trial(s) available for imiquimod and Breast Cancer
| Article | Year |
|---|---|
Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod.
Topics: Adult; Aged; Breast Neoplasms; CD8-Positive T-Lymphocytes; Female; Gene Expression Profiling; Humans; Imiquimod; Immunity, Cellular; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Th1 Cells | 2019 |
Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases: A Phase 2 Clinical Trial.
Topics: Administration, Cutaneous; Administration, Intravenous; Aged; Aged, 80 and over; Albumins; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Humans; Imiquimod; Lymphocytes, Tumor-Infiltrating; Middle Aged; Monocytes; Paclitaxel; Programmed Cell Death 1 Receptor; Salvage Therapy; Skin Neoplasms; Treatment Outcome | 2017 |
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Cytokines; Female; Humans; Imiquimod; Middle Aged; Skin Neoplasms; T-Lymphocytes; Toll-Like Receptor 7; Treatment Outcome; Tumor Microenvironment | 2012 |
10 other study(ies) available for imiquimod and Breast Cancer
| Article | Year |
|---|---|
Imiquimod-gemcitabine nanoparticles harness immune cells to suppress breast cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Deoxycytidine; Female; Gemcitabine; Humans; Imiquimod; Mice; Nanoparticles | 2022 |
The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease.
Topics: Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Quality of Life; Vulvar Neoplasms | 2022 |
Vulvar Paget's disease: outcomes of 51 patients treated with imiquimod cream.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Paget Disease, Extramammary; Retrospective Studies; Vulvar Neoplasms | 2022 |
Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Macrophages; Mice; Mice, Inbred BALB C; Micelles; Neoplasms, Experimental; Polyesters; Polyethylene Glycols; Polymers; Toll-Like Receptor 7; Tumor Microenvironment | 2019 |
Imiquimod in the treatment of breast cancer skin metastasis.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Disease Progression; Fatal Outcome; Female; Humans; Imiquimod; Pain; Skin Neoplasms; Treatment Outcome | 2014 |
Breast cancer treatment with imiquimod: applying an old lotion to a new disease.
Topics: Aminoquinolines; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Imiquimod; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Skin Neoplasms; Toll-Like Receptor 7 | 2012 |
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Breast Neoplasms; Carcinoma, Basal Cell; Chemotaxis, Leukocyte; Female; Humans; Imiquimod; Interferon Type I; Lymphocytes; Melanoma; Membrane Glycoproteins; Receptors, Cell Surface; Receptors, Chemokine; Receptors, CXCR3; Signal Transduction; Skin; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptors | 2005 |
Topical imiquimod to treat recurrent breast cancer.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Imiquimod; Skin Neoplasms | 2005 |
Clinical and histopathologic observations of the action of imiquimod in an epithelioid hemangioendothelioma and Paget's mammary disease.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Facial Neoplasms; Female; Hemangioendothelioma, Epithelioid; Humans; Imiquimod; Middle Aged; Paget's Disease, Mammary | 2006 |
Treatment of mammary and extramammary Paget's skin disease with topical imiquimod.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Breast Neoplasms; Diagnosis, Differential; Female; Groin; Humans; Imiquimod; Paget Disease, Extramammary; Paget's Disease, Mammary; Skin Neoplasms | 2006 |